Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
IET Systems Biology|March 18, 2017
Flatness-based control approach to drug infusion for cardiac function regulationGerasimos Rigatos, Nikolaos Zervos, Alexey Melkikh
World Journal of Gastroenterology|November 27, 2008
Concomitant gastric adenocarcinoma and stromal tumor in a woman with polymyalgia rheumaticaPanteleimon Kountourakis, Niki Arnogiannaki, Ilias Stavrinides, et al.
Anticancer Research|January 2, 2010
Biweekly gemcitabine (GEM) in combination with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancerAlexandros Ardavanis, Panteleimon Kountourakis, Athanassios Karagiannis, et al.
BMC Cancer|September 25, 2009
Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review studyAlexandros Ardavanis, Dimitrios Doufexis, Panteleimon Kountourakis, et al.
In Vivo (Athens, Greece)|September 26, 2009
Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature reviewAlexandros Ardavanis, Despina Sykoutri, Panteleimon Kountourakis, et al.
The Oncologist|May 2, 2008
Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancerAlexandros Ardavanis, Panteleimon Kountourakis, Flora Kyriakou, et al.
Cancer Immunology, Immunotherapy : CII|August 13, 2010
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancerEleni G Iliopoulou, Panteleimon Kountourakis, Michalis V Karamouzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Increased frequency of CD4+ cells expressing CD161 in cancer patientsEleni G Iliopoulou, Michalis V Karamouzis, Ioannis Missitzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patientsSonia A Perez, Michael V Karamouzis, Dimosthenes V Skarlos, et al.
Pageof 1